DE2456628A1 - Verduennungsmittel fuer biologisch aktives material - Google Patents
Verduennungsmittel fuer biologisch aktives materialInfo
- Publication number
- DE2456628A1 DE2456628A1 DE19742456628 DE2456628A DE2456628A1 DE 2456628 A1 DE2456628 A1 DE 2456628A1 DE 19742456628 DE19742456628 DE 19742456628 DE 2456628 A DE2456628 A DE 2456628A DE 2456628 A1 DE2456628 A1 DE 2456628A1
- Authority
- DE
- Germany
- Prior art keywords
- diluent
- enzyme
- dilution
- human serum
- active material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000011149 active material Substances 0.000 title claims description 5
- 238000010790 dilution Methods 0.000 title description 13
- 239000012895 dilution Substances 0.000 title description 13
- 239000003085 diluting agent Substances 0.000 claims description 40
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 7
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 description 27
- 108090000790 Enzymes Proteins 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 210000002966 serum Anatomy 0.000 description 17
- 230000000694 effects Effects 0.000 description 10
- 239000012153 distilled water Substances 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 238000004090 dissolution Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 5
- 102000013563 Acid Phosphatase Human genes 0.000 description 5
- 108010051457 Acid Phosphatase Proteins 0.000 description 5
- 108010088751 Albumins Proteins 0.000 description 5
- 102000009027 Albumins Human genes 0.000 description 5
- 239000011324 bead Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 4
- 102000004420 Creatine Kinase Human genes 0.000 description 4
- 108010042126 Creatine kinase Proteins 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229910001425 magnesium ion Inorganic materials 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- ONSKGPPTXAPQON-UHFFFAOYSA-N fluoromethane dihydrochloride Chemical compound Cl.Cl.FC ONSKGPPTXAPQON-UHFFFAOYSA-N 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 229940085991 phosphate ion Drugs 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Inorganic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Enzymes And Modification Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41997473A | 1973-11-29 | 1973-11-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2456628A1 true DE2456628A1 (de) | 1975-06-05 |
Family
ID=23664542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19742456628 Pending DE2456628A1 (de) | 1973-11-29 | 1974-11-29 | Verduennungsmittel fuer biologisch aktives material |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JPS5082282A (enExample) |
| DE (1) | DE2456628A1 (enExample) |
| FR (1) | FR2253074B1 (enExample) |
| GB (1) | GB1480089A (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5227305A (en) * | 1988-05-13 | 1993-07-13 | Instrumentation Laboratory Spa | Buffer solution systems for standardizing pH analyzers and electrolytes |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55156589A (en) * | 1979-05-25 | 1980-12-05 | Baiorisaac Center:Kk | Enzymatic treatment of water-insoluble substrate |
| NL8500266A (nl) * | 1985-01-31 | 1986-08-18 | Stichting Gastransport | Ijkoplossing voor ion-selectieve elektroden, droog materiaal om het uit aan te maken, werkwijze voor het bereiden daarvan, en toepassing daarvan. |
| CN102115737B (zh) * | 2009-12-31 | 2015-06-03 | 深圳迈瑞生物医疗电子股份有限公司 | 稳定碱性磷酸酶或其标记物的试剂和方法 |
-
1974
- 1974-11-27 JP JP13566574A patent/JPS5082282A/ja active Pending
- 1974-11-28 FR FR7438999A patent/FR2253074B1/fr not_active Expired
- 1974-11-28 GB GB5160674A patent/GB1480089A/en not_active Expired
- 1974-11-29 DE DE19742456628 patent/DE2456628A1/de active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5227305A (en) * | 1988-05-13 | 1993-07-13 | Instrumentation Laboratory Spa | Buffer solution systems for standardizing pH analyzers and electrolytes |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2253074B1 (enExample) | 1978-09-22 |
| FR2253074A1 (enExample) | 1975-06-27 |
| GB1480089A (en) | 1977-07-20 |
| JPS5082282A (enExample) | 1975-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69104903T2 (de) | Medium für die Elektrophorese. | |
| DE4405249C2 (de) | Stabilisierte Troponin-Zubereitung für Immunoassays und Verfahren zur Stabilisierung von Troponin für Immunoassays | |
| DE2548963C3 (de) | Verfahren und Mittel zur Bestimmung der Aktivität von Creatinkinase-MB | |
| DE1698180B2 (de) | Verfahren zur herstellung eines blutserum-bezugsnormals | |
| DE2008493C3 (de) | Hämatologische Kontrollflüssigkeit | |
| DE69330187T2 (de) | Verwendung einer ionen-selektiven polymermembran zur bestimmung von heparin | |
| DE1648999C3 (de) | Verfahren zur immunochemischen Bestimmung von Antigenen und Antikörpern | |
| DE19781871B4 (de) | Testpatrone zur Bewertung der Blutplättchen-Funktionalität | |
| DE2602997C2 (de) | Lyophilisierte Kollagenzubereitung und Verfahren zu ihrer Herstellung | |
| DE2134928B2 (de) | Immunologisches Reagens und Verfahren zu seiner Herstellung | |
| DE68912115T2 (de) | Ausscheidungsverfahren für die herstellung von thromboplastinreagenzien. | |
| DE69433776T2 (de) | Reagenz und verfahren für seine anwendung | |
| DE3006769C2 (enExample) | ||
| DE60032001T2 (de) | Verfahren zur stabilisierung von thrombin | |
| DE69319693T2 (de) | Formulierung zur Stabilisierung der enzymatischen Aktivität und immunreaktivität von Creatinkinase und Creatinkinase-Isoenzymen | |
| DE2456628A1 (de) | Verduennungsmittel fuer biologisch aktives material | |
| Haljamäe | Sampling of Nanoliter Volumes of Mammalian Subcutaneous Tissue Fluid and Ultra‐micro Flame Photometric Analyses of the K and Na Concentrations | |
| DE69016858T2 (de) | Verfahren und Reagenziensatz zur Bestimmung der funktionalen Aktivität von Protein S in menschlichem Plasma. | |
| CH628929A5 (en) | Reagent for the determination of lipase activity and process for its preparation | |
| DE68908764T2 (de) | Pufferlösungssysteme und Elektrolyten zur Eichung von Analysegeräten. | |
| CH645670A5 (de) | Diagnostisches mittel. | |
| DE2907228C2 (de) | Immunochemische Bestimmung zur Bestimmung der LDH↓1↓-Aktivität | |
| DE112013002316T5 (de) | Systeme und Verfahren für Assays von im nicht-nüchternen Zustand gewonnenem LDL-Cholesterin | |
| DE3344607A1 (de) | Verfahren und zusammensetzung fuer die bestimmung der phagocytischen reaktion | |
| DE69030135T2 (de) | Ein Reagenssystem zur Bestimmung von Lipase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OHJ | Non-payment of the annual fee |